Can the stroma provide the clue to the cellular basis for mammographic density?

Breast Cancer Research

Volumn 5, Issue 5, 2003, Pages 225-227

  Warren, Ruth ^a   Lakhani, Sunil R ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Breast cancer risk; Mammographic density; Stromal proteins

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN; DECORIN; LUMICAN;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CELL; BREAST DUCT; BREAST EPITHELIUM; CANCER RISK; CELL PROLIFERATION; CYTOPATHOLOGY; DENSITY; EVIDENCE BASED MEDICINE; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HYPOTHESIS; MAMMOGRAPHY; MENSTRUAL CYCLE; PHENOTYPE; STROMA; VALIDATION PROCESS;

BREAST; FEMALE; HUMANS; MAMMOGRAPHY; RISK FACTORS; STROMAL CELLS;

EID: 0041825589     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr642     Document Type: Article

References (26)

1. Alowami S, Troup S, Al-Haddad S, Kirkpatrick I, Watson P: Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res 2003, 5:R129-R135.
2. Wolfe JN: Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer 1976, 37:2486-2492.
3. Heine JJ, Malhotra P: Mammographic tissue, breast cancer risk, serial image analysis, and digital mammography. Part 2. Serial breast tissue change and related temporal influences. Acad Radiol 2002, 9:317-335.
4. Heine JJ, Malhotra P: Mammographic tissue, breast cancer risk, serial image analysis, and digital mammography. Part 1. Tissue and related risk factors. Acad Radiol 2002, 9:298-316.
5. Byrne C: Studying mammographic density: implications for understanding breast cancer [editorial; comment]. J Natl Cancer Inst 1997, 89:531-533.
6. Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MR, Giles GG, Tritchler D, Chiarelli A, Yaffe MJ, Hopper JL: Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 2002, 347:886-894.
7. Vachon CM, Kuni CC, Anderson K, Anderson VE, Sellers TA: Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control 2000, 11:653-662.
8. Atkinson C, Warren R, Bingham SA, Day NE: Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen. Cancer Epidemiol Biomarkers Prev 1999, 8: 863-866.
9. Sala E, Warren R, Duffy S, Welch A, Luben R, Day N: High risk mammographic parenchymal patterns and diet: a case-control study. Br J Cancer 2000, 83:121-126.
10. Sala E, Warren R, McCann J, Duffy S, Luben R, Day N: High-risk mammographic parenchymal patterns and anthropometric measures: a case-control study. Br J Cancer 1999, 81:1257-1261.
11. van Gils CH, Otten JD, Verbeek AL, Hendriks JH: Short communication: breast parenchymal patterns and their changes with age. Br J Radiol 1995, 68:1133-1135.
12. Sala E, Solomon L, Warren R, McCann J, Duffy S, Luben R, Day N: Size, node status, and grade of breast tumours: association with mammographic parenchymal patterns. Eur Radiol 2000, 10:157-161.
13. Sala E, Warren R, McCann J, Duffy S, Luben R, Day N: Mammographic parenchymal patterns and breast cancer natural history - a case-control study. Acta Oncol 2001, 40:461-465.
14. Boyd NF, Martin LJ, Stone J, Greenberg C, Minkin S, Yaffe MJ: Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention. Curr Oncol Rep 2001, 3:314-321.
15. Bartow S, Pathak D, Mettler F: Radiographic microcalcification and parenchymal pattern as indicators of histologic 'high-risk' benign breast disease. Cancer 1990, 66:1721-1725.
16. Friedenreich C, Bryant H, Alexander F, Hugh J, Danylik J, Page D: Risk factors for benign breast biopsies: a nested case-control study in the Alberta breast screening programme. Cancer Detect Prev 2001, 25:280-291.
17. Kaufhold J, Thomas J, Eberhard J, Galbo C, Trotter D: A calibration approach to glandular tissue composition estimation in digital mammography. Med Phys 2002, 29:1867-1880.
18. Lee N, Rusinek H, Weinreb J, Chandra R, Toth H, Singer C, Newstead G: Fatty and fibroglandular tissue volume in the breasts of women 20-83 years old: comparison of X-ray mammography and computer-assisted MR imaging. Am J Roentgenol 1997, 168:501-506.
19. Arthur JE, Ellis IO, Flowers C, Roebuck E, Elston CW, Blamey RW: The relationship of 'high risk' mammographic patterns to histological risk factors for development of cancer in the human breast. Br J Radiol 1990, 63:845-849.
20. Boyd NF, Jensen H, Cooke G, Lee Han H, Lockwood G, Miller A: Mammographic densities and the prevalence and incidence of histological types of benign breast disease. Eur J Cancer Prev 2000, 9:15-24.
21. Byrne C, Schairer C, Brinton L, Wolfe J, Parekh N, Salane M, Carter C, Hoover R: Effects of mammographic density and benign breast disease on breast cancer risk. Cancer Causes Control 2001, 12:103-110.
22. Kurose K, Hoshaw-Woodward S, Adeyinka A, Lemeshow S, Watson P, Eng C: Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions. Hum Mol Genet 2001, 10:1907-1913.
23. Guo Y, Martin L, Hanna W, Banerjee D, Miller N, Fishell E, Khokha R, Boyd NF: Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev 2001, 10:243-248.
24. White E, Velentgas P, Mandelson M, Lehman C, Elmore J, Porter P: Variation in mammographic breast density by time in menstrual cycle among women aged 40-49 years. J Natl Cancer Inst 1998, 90:906-910.
25. Colacurci N, Fornaro F, De Francisco P, Mele D, Palermo M, del Ve W: Effects of a short-term suspension of hormone replacement therapy on mammographic density. Fertil Steril 2001, 76:451-455.
26. Leygue E, Snell L, Dotzlaw H, Troup S, Hiller-Hitchcock T, Murphy L, Roughley PJ, Watson PH: Lumican and decorin are differently expressed in human breast carcinoma. J Pathol 2000, 192:313-320.